navitoclax
Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Reference standards of Navitoclax API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Navitoclax - API Standards
[catalogue_number] => PA 14 82000
[category_ids] => ,69,81,78,70,82,88,
[chemical_name] =>
[weight] => 974.61
[form] => C47H55ClF3N5O6S3
[cas] => 923564-51-6
[pslug] => 923564-51-6-navitoclax-api-pa1482000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Navitoclax - API Standards
Catalogue No.:PA 14 82000
Molecular Formula : C47H55ClF3N5O6S3
Molecular Weight : 974.61